Another interesting finding is the observation of high PD-L1 expression and lack of treatable driver mutation raises the potential of checkpoint immunotherapy for the rare type of lung tumor - lymphoepithelioma-like carcinoma (26). This evidence concerns the gene CD274 and nasopharyngeal type undifferentiated carcinoma.